Boston Scientific Corporation
BSX
Hisse Senetlerindeki Sıralama
#409
Bu şirket açıklaması yalnızca İngilizce olarak sunulmaktadır.
Boston Scientific Corporation (BSX) operates as a global leader in medical... Boston Scientific Corporation (BSX) operates as a global leader in medical technology, specializing in the design, manufacturing, and commercialization of innovative medical devices tailored for a diverse array of interventional medical specialties across the globe. Its business is strategically organized into three principal segments: MedSurg, Rhythm and Neuro, and Cardiovascular. Within these divisions, the company provides a comprehensive portfolio of solutions addressing various gastrointestinal and pulmonary ailments, as well as urological and pelvic health concerns. This extends to advanced implantable devices for managing cardiac rhythm disorders, such as cardioverter-defibrillators, cardiac resynchronization therapy devices, and pacemakers, complemented by remote patient management systems. Furthermore, Boston Scientific offers sophisticated technologies for diagnosing and treating complex heart rate and rhythm irregularities. These encompass 3-D cardiac mapping and navigation tools, along with a suite of specialized catheters (including ablation, diagnostic, mapping, and intracardiac ultrasound types), delivery sheaths, and related accessories. Its offerings also extend to neurological conditions, providing spinal cord stimulator systems for chronic pain management, indirect decompression systems, and deep brain stimulation systems. In the realm of interventional cardiology, the company's innovations include drug-eluting coronary stent systems designed for treating coronary artery disease, products for percutaneous coronary interventions to combat atherosclerosis, and intravascular imaging catheters (such as ultrasound and fractional flow reserve devices) for assessing coronary arteries, heart chambers, and peripheral vessels. It also develops structural heart therapies. Beyond this, Boston Scientific supplies an array of stents, balloon catheters, wires, and atherectomy systems for the treatment of arterial diseases. For venous conditions, it provides thrombectomy and acoustic pulse thrombolysis systems, alongside wires and stents. Critically, the company also contributes to cancer treatment through peripheral embolization devices, radioactive microspheres, various ablation systems (including cryotherapy), and micro and drainage catheters. The organization was established in 1979 and maintains its corporate headquarters in Marlborough, Massachusetts.
Hisse Fiyatı
$41.88
Son senkronizasyon: 2026-10-30
Piyasa Değeri
$60.69B
Değişim (1 gün)
-1.89%
Değişim (1 yıl)
-58.42%
Ülke
US
Hisse senedi verileri: Financial Modeling Prep·Güncelleme: ·Yatırım tavsiyesi değildir·Nasıl hesaplıyoruz
Ticaret Boston Scientific Corporation (BSX)
Kategori
Healthcare
Boston Scientific Corporation (BSX) için gelir
Sep 2026 itibarıyla gelir TTM: $21.07B
Boston Scientific Corporation şirketinin en son finansal raporlarına göre, mevcut geliri (TTM) $21.07B'dir. 2025 yılında şirketin geliri $20.07B önceki yıla göre artış 2024 yılındaki $16.75B gelirine göre. Gelir, bir şirketin mal veya hizmet satışından elde ettiği toplam tutardır. Kazançtan farklı olarak, hiçbir gider düşülmez.
Boston Scientific Corporation için 2000 ile 2026 arasındaki gelir geçmişi
Her yılın sonunda gelir
| Yıl | Gelir | Değişim |
|---|---|---|
| 2026 (TTM) | $21.07B | 4.96% |
| 2025 | $20.07B | 19.87% |
| 2024 | $16.75B | 17.61% |
| 2023 | $14.24B | 12.29% |
| 2022 | $12.68B | 6.68% |
| 2021 | $11.89B | 19.92% |
| 2020 | $9.91B | -7.66% |
| 2019 | $10.74B | 9.28% |
| 2018 | $9.82B | 8.57% |
| 2017 | $9.05B | 7.89% |
| 2016 | $8.39B | 12.16% |
| 2015 | $7.48B | 1.31% |
| 2014 | $7.38B | 3.32% |
| 2013 | $7.14B | -1.46% |
| 2012 | $7.25B | -4.89% |
| 2011 | $7.62B | -2.36% |
| 2010 | $7.81B | -4.67% |
| 2009 | $8.19B | 1.71% |
| 2008 | $8.05B | -3.67% |
| 2007 | $8.36B | 6.85% |
| 2006 | $7.82B | 24.48% |
| 2005 | $6.28B | 11.72% |
| 2004 | $5.62B | 61.80% |
| 2003 | $3.48B | 19.08% |
| 2002 | $2.92B | 9.20% |
| 2001 | $2.67B | 0.34% |
| 2000 | $2.66B | 0.00% |
Benzer şirketler veya rakiplerin geliri
| Şirket | Gelir | Gelir Farkı | Ülke |
|---|---|---|---|
| $48.23B | 128.91% |
US
|
|
| $37.54B | 78.19% |
IE
|
|
| $26.30B | 24.83% |
US
|
|
| $25.84B | 22.63% |
DE
|
|
| $6.51B | -69.09% |
US
|
Boston Scientific Corporation geliri hakkında sorular
Boston Scientific Corporation geliri ne kadar?
Eyl 2026 itibarıyla Boston Scientific Corporation geliri son on iki ayda $21.07B oldu.
Boston Scientific Corporation geliri 2025 yılında ne kadardı?
2025 yılında Boston Scientific Corporation geliri, 2024 yılına ($16.75B) göre 19.87% artarak $20.07B oldu.
Boston Scientific Corporation geliri 2020 yılından bu yana nasıl değişti?
2020–2025 döneminde Boston Scientific Corporation geliri $9.91B seviyesinden $20.07B seviyesine geldi; bu, yıllık ortalama 15.16% artış anlamına geliyor.
Boston Scientific Corporation geliri benzer şirketlerle karşılaştırıldığında nasıl?
Boston Scientific Corporation geliri ($21.07B), yukarıda listelenen 5 benzer şirketin 1 tanesinden daha yüksek. Bu şirketler arasında en yüksek değer $48.23B ile Abbott Laboratories şirketine ait.